A detailed history of Guyasuta Investment Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 24,015 shares of ABT stock, worth $2.73 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
24,015
Previous 24,015 -0.0%
Holding current value
$2.73 Million
Previous $2.73 Million 8.57%
% of portfolio
0.17%
Previous 0.19%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $901 - $1,104
-10 Reduced 0.04%
24,015 $2.64 Million
Q3 2023

Oct 25, 2023

SELL
$95.53 - $114.62 $10,126 - $12,149
-106 Reduced 0.44%
24,025 $2.33 Million
Q2 2023

Jul 17, 2023

BUY
$100.78 - $112.29 $7,659 - $8,534
76 Added 0.32%
24,131 $2.63 Million
Q4 2022

Jan 30, 2023

BUY
$95.06 - $111.52 $47,530 - $55,760
500 Added 2.12%
24,055 $2.64 Million
Q3 2022

Oct 25, 2022

SELL
$96.76 - $112.03 $15,578 - $18,036
-161 Reduced 0.68%
23,555 $2.28 Million
Q2 2022

Jul 21, 2022

SELL
$102.07 - $123.37 $18,372 - $22,206
-180 Reduced 0.75%
23,716 $2.58 Million
Q1 2022

May 03, 2022

BUY
$114.02 - $139.04 $22,804 - $27,808
200 Added 0.84%
23,896 $2.83 Million
Q4 2021

Feb 08, 2022

SELL
$115.53 - $141.46 $8,549 - $10,468
-74 Reduced 0.31%
23,696 $3.34 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $7,405 - $8,717
70 Added 0.3%
23,770 $2.76 Million
Q1 2021

May 11, 2021

SELL
$108.84 - $128.23 $25,033 - $29,492
-230 Reduced 0.96%
23,700 $2.84 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $50,085 - $54,578
477 Added 2.03%
23,930 $2.62 Million
Q3 2020

Oct 28, 2020

BUY
$91.64 - $111.29 $55,442 - $67,330
605 Added 2.65%
23,453 $2.55 Million
Q2 2020

Aug 06, 2020

BUY
$76.57 - $98.0 $4,594 - $5,880
60 Added 0.26%
22,848 $2.09 Million
Q1 2020

Apr 28, 2020

BUY
$62.82 - $91.86 $4,837 - $7,073
77 Added 0.34%
22,788 $1.8 Million
Q4 2019

Feb 10, 2020

BUY
$78.51 - $87.4 $186,853 - $208,012
2,380 Added 11.71%
22,711 $1.97 Million
Q3 2019

Nov 08, 2019

SELL
$81.84 - $88.74 $96,162 - $104,269
-1,175 Reduced 5.46%
20,331 $1.7 Million
Q1 2019

May 10, 2019

SELL
$66.22 - $80.06 $1,390 - $1,681
-21 Reduced 0.1%
21,506 $1.72 Million
Q3 2018

Nov 08, 2018

SELL
$60.81 - $73.36 $6,689 - $8,069
-110 Reduced 0.51%
21,527 $1.58 Million
Q1 2018

May 09, 2018

BUY
$56.27 - $63.62 $42,821 - $48,414
761 Added 3.65%
21,637 $1.3 Million
Q4 2017

Feb 12, 2018

BUY
$53.68 - $57.47 $1,127 - $1,206
21 Added 0.1%
20,876 $1.19 Million
Q2 2017

Aug 09, 2017

BUY
N/A
20,855
20,855 $1.01 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Guyasuta Investment Advisors Inc Portfolio

Follow Guyasuta Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.